Evidence map›Paper›PMID 22926418›Full record

ArticleJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2012

Regulation of mu opioid receptor expression in developing T cells.

Lily Zhang, Judith Sliker Belkowski, Tammi Briscoe, Thomas J Rogers

Abstract read
In one paragraph

Article in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Opioid Signaling in Multiple Sclerosis: Emerging Targets for Repair.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Expression of Opioid Receptors in Cells of the Immune System.International journal of molecular sciences · 2020
    Review
  10. Article
  11. Article
  12. The molecular basis for neuroimmune receptor signaling.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2012
    Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Lily ZhangCenter for Substance Abuse Research, Center for Inflammation, Translational and Clinical Lung Research, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Judith Sliker Belkowski
Tammi Briscoe
Thomas J Rogers
Temple College · USTemple University · US

Funding

Pilot Projects Core (PPC)P30DA013429 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI Anjali M Rajadhyaksha · 2000 to 2026
$34.6M
OPIOIDS IN AIDS PROGRESSION AND NEUROPATHOGENESIS OF SIV INFECTED MACAQUESP01DA023860 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI FISCHER, TRACY · 2008 to 2012
$7.0M
OPIOIDS, OPIOID RECEPTORS, AND IMMUNE COMPETENCER01DA006650 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI ADLER, MARTIN W · 1991 to 2012
$5.0M
Opioid &Chemokine Receptor Interactions Relative to HIVR01DA014230 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI ROGERS, THOMAS J · 2001 to 2016
$5.0M
Opioid Modulation of Inflammatory Monocyte Activity Involved in HIV SusceptibilitR01DA025532 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI ROGERS, THOMAS J · 2008 to 2012
$1.5M
HIV INFECTION AND OPIOID-INDUCED IMMUNOREGULATIONR01DA016544 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI ROGERS, THOMAS J · 2003 to 2007
$1.1M
Flourescence-Activated Cell SorterS10RR027910 · NCRR · TEMPLE UNIV OF THE COMMONWEALTH · PI ROGERS, THOMAS J · 2010 to 2010
$499k
NCRR NIH HHS S10 RR027910NIDA NIH HHS DA06650NIDA NIH HHS DA14230NIDA NIH HHS DA16544NIDA NIH HHS P01 DA023860NIDA NIH HHS P30 DA013429NIDA NIH HHS P30DA13429NIDA NIH HHS R01 DA006650NIDA NIH HHS R01 DA014230NIDA NIH HHS R01 DA016544NIDA NIH HHS R01 DA025532
6 · The paper itself

Abstract

We have previously reported that functionally active μ-opioid receptors (MOR) are constitutively expressed at relatively low levels by developing T cells in the thymus. However, very little is known about the regulation of MOR expression by immature T cells. In this report, we first attempted to determine the effect of T cell receptor-induced T cell activation on the expression of MOR. We activated T cells with either the combination of anti-CD3 and CD28, or with superantigen, and observed a substantial increase in MOR transcript expression. We also chose to examine the effect of cytokine-mediated T cell activation on the expression of this opioid receptor. We selected certain cytokines that play a role in T cell development and are known to be present at functional levels in the thymus gland. Our results show that interferon γ (IFNγ), IL-1β, and IL-2, and in particular transforming growth factor-β (TGFβ), all induced significant increases in MOR transcript expression. On the other hand, both TNFα and IL-7 exhibited much weaker effects on MOR expression. These results show that MOR expression by developing T cells is strongly regulated by several cytokines involved in T cell development in the thymus gland.

Indexed as

AnimalsBlotting, SouthernCell DifferentiationCyclic AMPInterferon-gammaInterleukin-1betaInterleukin-2Interleukin-7Lymphocyte ActivationMiceMice, Inbred C57BLReceptors, Opioid, muRNAThymus GlandT-LymphocytesTransforming Growth Factor betaCyclic AMPInterferon-gammaInterleukin-1betaInterleukin-2Interleukin-7Receptors, Opioid, muRNATransforming Growth Factor betaTumor Necrosis Factor-alpha

Identifiers

PMID22926418
PMCPMC3518723
OpenAlexW2130729099

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.